HKD33.65
2.12% today
Hong Kong, Apr 02, 10:08 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Stock price

HKD33.65
-1.85 5.21% 1M
-2.20 6.14% 6M
+5.55 19.75% YTD
+5.90 21.26% 1Y
-18.95 36.03% 3Y
-76.35 69.41% 5Y
-76.35 69.41% 10Y
Hong Kong, Closing price Wed, Apr 02 2025
+0.70 2.12%
ISIN
KYG5074A1004
Symbol
6618
Index
Sector

Key metrics

Market capitalization HKD105.43b
Enterprise Value HKD54.39b
P/E (TTM) P/E ratio 23.15
EV/Sales (TTM) EV/Sales 0.86
P/S ratio (TTM) P/S ratio 1.67
P/B ratio (TTM) P/B ratio 1.88
Revenue growth (TTM) Revenue growth 6.51%
Revenue (TTM) Revenue HKD63.06b
EBIT (operating result TTM) EBIT HKD1.26b
EPS (TTM) EPS HKD1.42
P/E forward 26.98
P/S forward 1.49
EV/Sales forward 0.77
Show more

Is JD Health International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

JD Health International Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a JD Health International forecast:

15x Buy
71%
4x Hold
19%
2x Sell
10%

Analyst Opinions

21 Analysts have issued a JD Health International forecast:

Buy
71%
Hold
19%
Sell
10%

Financial data from JD Health International

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
63,059 63,059
7% 7%
100%
- Direct Costs 48,630 48,630
6% 6%
77%
14,429 14,429
10% 10%
23%
- Selling and Administrative Expenses 11,494 11,494
6% 6%
18%
- Research and Development Expense 1,443 1,443
6% 6%
2%
1,493 1,493
53% 53%
2%
- Depreciation and Amortization 233 233
7% 7%
0%
EBIT (Operating Income) EBIT 1,260 1,260
74% 74%
2%
Net Profit 4,512 4,512
89% 89%
7%

In millions HKD.

Don't miss a Thing! We will send you all news about JD Health International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. Its technology-driven platform is cantered on the supply chain of pharmaceutical and healthcare products and healthcare services, encompassing a user’s full life span for all healthcare needs. The firm's retail pharmacy business operates through three models: direct sales, online marketplace and Omni channel initiative. It offers comprehensive online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor and consumer healthcare. Its platform allows doctors to practice multisite, acquire and manage targeted patients, conduct healthcare research, exchange academic and clinical knowledge and improve diagnostic and treatment skills. The company was founded on November 30, 2018 and is headquartered in Beijing, China.

Head office Cayman Islands
CEO En Jin
Employees 3,564
Founded 2018
Website www.health.jd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today